Rising adoption of automated and AI-enabled synthesis platforms positions pharmaceutical and biotechnology companies for ...
According to Precedence Research, the global peptide therapeutics market size is projected to surpass USD 87.21 billion by ...
Vapourtec's Peptide-Builder, a fully automated, high-throughput benchtop peptide synthesizer, has been designed to redefine solid-phase peptide synthesis (SPPS). Compact, efficient and intuitive, it ...
SHANGHAI--(BUSINESS WIRE)--AmbioPharm, a worldwide leader in peptide API CDMO services, continues growth to meet capacity demands for late phase and commercial peptide production. A reliable peptide ...
A major problem in solid-phase peptide synthesis (SPPS) is aggregation and poor solvation leading to incomplete deprotection and/or coupling steps, resulting in low crude purity peptides. 1 This ...
The "Peptide and Oligonucleotide CDMO Market Forecast to 2033" has been added to ResearchAndMarkets.com's offering.The global ...
The Peptide-ExplorerLT ™ is designed for scientists who need to optimize and explore linear peptide synthesis. The product is a high-spec flow chemistry system that uses continuous flow. The product ...
NORTH AUGUSTA, S.C.--(BUSINESS WIRE)--AmbioPharm, a worldwide leader in peptide API CDMO services, continues growth to meet capacity demands for late phase and commercial peptide production while ...
Therapeutic peptides constitute an unusual drug category. Although most therapeutic peptides are synthetic, their molecular weights are well above those of small-molecule drugs, but well below those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback